Arnold’s Back in Action: FUBAR Season 2 Confirmed by Netflix!
After a wildly entertaining first season filled with action, comedy, and Arnold Schwarzenegger’s iconic presence, FUBAR Season 2 is officially in the works—and fans couldn’t be more excited. From the anticipated FUBAR Season 2 release date to the FUBAR Season 2 cast, here's everything you need to know about the return of Netflix's adrenaline-pumping spy comedy.
What Is FUBAR About?
FUBAR, which stands for “Fouled Up Beyond All Recognition,” follows CIA operative Luke Brunner (played by Arnold Schwarzenegger) who is ready to retire when he discovers a shocking family secret—his daughter is also a CIA agent. The show blends father-daughter drama with espionage antics, leading to hilarious and heartwarming chaos.
Premiering in May 2023, FUBAR Season 1 garnered praise for its blend of action and humor, giving long-time fans of Schwarzenegger a new side of the legendary actor.
FUBAR Season 2 Release Date: When Will It Premiere?
The burning question on everyone’s mind is: When is the FUBAR Season 2 release date?
Netflix confirmed FUBAR Season 2 during its annual TUDUM event in 2023, much to the delight of fans. While there is no official release date yet, industry insiders expect the new season to drop sometime in late 2025, potentially around November or December, based on the production timeline of the first season.
Production for Season 2 reportedly began earlier this year, meaning post-production and promotional work are likely underway. Keep your eyes on Netflix's official channels for the official FUBAR Season 2 release date announcement.
FUBAR Season 2 Cast: Who’s Returning?
One of the highlights of the show is its well-rounded and dynamic cast. Here’s who is expected to return for FUBAR Season 2:
-
Arnold Schwarzenegger as
Luke Brunner -
Monica Barbaro as Emma Brunner
-
Fortune Feimster as Roo
-
Travis Van Winkle as Aldon
-
Milan Carter as Barry
-
Gabriel Luna as Boro
-
Fabiana Udenio as Tally Brunner
There are also rumors of new cast members joining for Season 2, potentially bringing in fresh antagonists and allies to shake things up. Netflix has hinted at “bigger missions” and “higher stakes,” suggesting the FUBAR Season 2 cast could grow significantly.
What Will FUBAR Season 2 Be About?
FUBAR Season 2 promises to dive deeper into the complicated relationship between Luke and Emma as they continue to navigate their CIA duties while trying to maintain some form of a normal family life.
Season 1 ended on a cliffhanger—with secrets exposed and loyalties tested. Season 2 is expected to pick up where things left off, with the Brunners facing both personal and professional fallout. Expect more globe-trotting missions, explosive action sequences, and sharp comedic banter.
Netflix has teased that Season 2 will feature "unexpected twists" and "emotional depth," so fans can expect not only laughs and explosions but also real character development.
Why FUBAR Season 2 Is Worth the Hype
There are plenty of reasons why FUBAR Season 2 is one of Netflix’s most anticipated shows:
-
Arnold’s TV comeback: Schwarzenegger’s first TV lead role was a hit. He brought charm, humor, and signature action to the small screen.
-
Strong chemistry: The dynamic between Monica Barbaro and Arnold is both hilarious and heartfelt.
-
Perfect mix of genres: FUBAR successfully blends spy thrillers with family comedy, offering something for everyone.
Whether you're a fan of action-packed espionage or family-centered humor, FUBAR Season 2 is shaping up to deliver.
How to Watch FUBAR Season 2
When the new season drops, it will be available exclusively on Netflix. Make sure your subscription is active and keep an eye on Netflix’s "New Releases" section to catch the premiere.
If you haven’t watched Season 1 yet, now is the perfect time to binge all eight episodes and get caught up before Season 2 premieres.
Get Ready for Another Wild Ride
The return of Arnold Schwarzenegger in FUBAR Season 2 is a major event for action and comedy fans alike. With more stunts, spy missions, and Brunner family drama on the way, the next season promises to raise the stakes and deliver more of what made Season 1 so enjoyable.
From what we know so far—an exciting returning FUBAR Season 2 cast, a likely late 2025 release date, and a continuation of explosive storylines—Season 2 is bound to be a hit.
Dad with deadly brain cancer that kills in a year is cancer free after taking new drug
A breakthrough drug is fighting brain cancer head-on.
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly aggressive disease — many patients survive just nine months after diagnosis.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
Treatment focuses on managing symptoms and extending life via surgery to remove as much of the tumor as possible and radiation therapy and chemotherapy to destroy cancer cells.
Now, researchers from University College London Hospitals are recruiting glioblastoma patients for a trial of the immunotherapy drug ipilimumab. Sold under the brand name Yervoy, the monoclonal antibody stimulates the immune system to recognize and attack cancer cells.
Oncologists are optimistic since a UK father shows no signs of having a tumor after he took ipilimumab before his glioblastoma treatment.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
“The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,” said Dr. Paul Mulholland, the consultant medical oncologist leading the trial.
“We saw with Ben, the one patient recruited to the immunotherapy study, NeAT-GLIO, that he has had clear scans since having the treatment and the tumor hasn’t returned more than two and a half years later.”
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
Trotman met with Mulholland, who enrolled him in a clinical trial for ipilimumab. He was the first patient in the world — and the only person in the trial — to take the drug before glioblastoma treatment.
“Getting this diagnosis was the most traumatic experience,” said Trotman’s wife, Emily.
“We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.”
After taking the drug, Ben underwent radiotherapy and chemotherapy.
Two years and eight months later, his scans are clear.
“It is very unusual to have a clear scan with glioblastoma, especially when he didn’t have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans,” Mulholland said.
Ben and Emily Trotman wed in 2023, after he began his immunotherapy treatment.
“We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay,” he added, “and it has so far, which we are delighted to see.”
In January 2023, months after his diagnosis, Ben married Emily. The couple welcomed a daughter, Mabel, earlier this year.
They enjoy taking her for walks along with their rescue dog, Jerry.
“We are trying to live as normal a life as possible,” Emily said.
“We are in a unique position of which there is no precedent and which comes with a great deal of uncertainty,” she continued. “We want to live each day as if it were our last, but we also want to plan for the future, which we hope to have.”
Researchers plan to recruit 16 glioblastoma patients like Ben over 18 months.
After taking ipilimumab, the trial participants will undergo radiotherapy and chemotherapy and perhaps surgery depending on the extent of their disease.
Dr. Paul Mulholland and Dame Siobhain McDonagh, who raised funds for the new clinical trial of ipilimumab.
The trial is being funded by Dame Siobhain McDonagh, a member of the British Parliament, whose sister died of glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” McDonagh said. “Changing this was Margaret’s final campaign and one that I have continued in her memory.”
Treatment will take place at the NIHR UCLH’s Clinical Research Facility at the National Hospital for Neurology and Neurosurgery.
“I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part,” Ben said. “It will give people newly diagnosed with glioblastoma some hope.”
